Clinical trials in Bratislava – page 12

277 clinical trials in Bratislava, Slovakia across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SlovakiaKlinickeSkusky.sk

Bratislava at a glance

277

clinical trials

Research sites6

Quick filters

277 trials in Bratislava

Open in trial search

Primary immunodeficiency syndrome

Not recruiting

Study on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases

Registered drugNo placebo

Study on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases

Registered drugNo placebo

Slovakia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Human Normal Immunoglobulin
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Hypertriglyceridaemia

Not recruiting

Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Investigational

Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Sponsor:Arrowhead Pharmaceuticals Inc.

Contact Research Centre

Colitis ulcerative+1

Not recruiting

Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

InvestigationalNo placebo

Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

InvestigationalNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Duvakitug
Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Contact Research Centre

Hypertriglyceridaemia

Not recruiting

Study to Evaluate Plozasiran for Adults with High Triglycerides

Investigational

Study to Evaluate Plozasiran for Adults with High Triglycerides

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Sponsor:Arrowhead Pharmaceuticals Inc.

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Barzolvolimab
Sponsor:Celldex Therapeutics Inc.

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

Registered drug

Study on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study on the Effects of Semaglutide in Patients with Early Alzheimer's Disease

Registered drug

Study on the Effects of Semaglutide in Patients with Early Alzheimer's Disease

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Primary immunodeficiency syndrome

Not recruiting

Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

InvestigationalNo placebo

Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

InvestigationalNo placebo

Slovakia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Human Normal Immunoglobulin
Sponsor:Baxalta Innovations GmbH

Contact Research Centre

Migraine+2

Not recruiting

Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety

Investigational

Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Atogepant
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Vitiligo

Not recruiting

Study of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

Registered drug

Study of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Dexamethasone
Sponsor:Pfizer Inc.

Contact Research Centre

Crohn's disease

Not recruiting

Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease

Investigational

Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Ozanimod
Sponsor:Celgene International II S.a.r.l.

Contact Research Centre

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Evolocumab
Sponsor:Amgen Inc.

Contact Research Centre

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Bratislava

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on non-small cell lung cancer and advanced breast cancer treatments. Studies include evaluation of novel therapies like sigvotatug vedotin and investigations into treatment combinations for metastatic prostate cancer.

Lung Cancer Therapeutics
Breast Cancer Treatment
Prostate Cancer Research

Research includes evaluations of combination therapies and targeted treatments for various stages of cancer.

02 Cardiovascular Studies

Comprehensive research into heart failure prevention and treatment of cardiovascular diseases. Studies examine innovative approaches using medications like baxdrostat and investigating treatments for patients following heart attacks.

Heart Failure Prevention
Post-Heart Attack Care
Cardiovascular Risk Management

Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.

03 Inflammatory Conditions

Studies addressing various inflammatory conditions including Crohn's disease and ulcerative colitis. Research evaluates new therapeutic approaches for chronic inflammatory disorders and autoimmune conditions.

Inflammatory Bowel Disease
Hidradenitis Suppurativa
Chronic Inflammatory Disorders

Trials aim to improve treatment options and quality of life for patients with chronic inflammatory conditions.

Back to Slovakia All countries